Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrooks Macdonald Regulatory News (BRK)

Share Price Information for Brooks Macdonald (BRK)

Share Price is delayed by 15 minutes
Get Live Data
1,330.00    5.00 (0.38%)
Bid:
1,335.00
Ask:
1,350.00
Spread: 15.00 (1.124%)
Market Cap: £205.46m
BRK Live PriceLast checked at - London Stock Exchange

Intraday Brooks Macdonald Share Chart

Director appointment

16 Feb 2023 07:00

RNS Number : 0700Q
Brooks Macdonald Group PLC
16 February 2023
 

16 February 2023

 

BROOKS MACDONALD GROUP PLC

 

Director appointment

 

Brooks Macdonald Group plc ("The Group", "Brooks Macdonald") is pleased to announce the appointment of James Rawlingson as Non-Executive Director effective 2 March 2023. James will in due course assume the role of Chairman of the Audit Committee, subject to regulatory approval.

 

James currently serves as Chairman of the Audit and Risk Committee at Citibank UK, Chairman of the Audit and Risk Assurance Committee at the Foreign Office's executive agency Wilton Park, and Chairman of the Board at Novai Ltd. In his executive career James has held senior positions at Coutts, UBS Wealth, Charles Stanley plc and Arix Bioscience plc.

 

Commenting on the appointment, Acting Chairman Richard Price said: "I am delighted that James is joining the Board. James has had an extensive career and his sector experience will provide valuable insight as the Company continues towards its strategic goals."

 

AIM disclosures

 

During the five years immediately preceding the date of this announcement, James Hedley Rawlingson, who is 55 years old, held the following directorships:

 

Current

 

Citibank UK Limited

Wilton Park (an Arm's Length Body of the British Foreign, Commonwealth & Development Office)

Novai Limited

 

Previous

 

Next Gen PPE limited

Arix Bioscience Holdings Limited

Arix Bioscience plc

Arthurian Life Sciences GP Limited

Als SPV Limited

Arix Capital Management Limited

Arthurian Life Sciences SPV GP Limited

 

There is no further information to be disclosed pursuant to Schedule Two Part (g) of the AIM Rules for Companies.

 

Enquiries to:

Brooks Macdonald Group plc

Andrew Shepherd, CEO

www.brooksmacdonald.com

020 7927 4816

 

Peel Hunt LLP (Nominated Adviser and Broker)

Paul Shackleton / Andrew Buchanan / John Welch

020 7418 8900

 

FTI Consulting

Laura Ewart / Katherine Bell

brooksmacdonald@fticonsulting.com

07711 387 085 / 07976 870 961

 

Notes to editors

 

Brooks Macdonald Group plc, through its various subsidiaries, provides leading investment management services in the UK and internationally. The Group, which was founded in 1991 and began trading on AIM in 2005, had discretionary Funds under Management of £16.2 billion as at 31 December 2022.

 

Brooks Macdonald offers a range of investment management services to private high net worth individuals, pension funds, institutions, charities and trusts. The Group also provides financial planning as well as international investment management, and acts as fund manager to a range of onshore and international funds.

 

The Group has fifteen offices across the UK and Crown Dependencies including London, Birmingham, Cheltenham, East Anglia, Exeter, Leeds, Manchester, Nuneaton, Southampton, Tunbridge Wells, Scotland, Wales, Jersey, Guernsey and Isle of Man.

 

LEI: 213800WRDF8LB8MIEX37

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUVSWROAUUAAR
Date   Source Headline
27th Feb 20257:00 amRNSPurchase of Own Shares
26th Feb 20257:00 amRNSPurchase of Own Shares
25th Feb 20257:00 amRNSPurchase of Own Shares
24th Feb 20257:00 amRNSSale of Brooks Macdonald International completed
21st Feb 20257:00 amRNSPurchase of Own Shares
20th Feb 20253:15 pmRNSHolding in Company
20th Feb 20257:00 amRNSPurchase of Own Shares
19th Feb 20257:00 amRNSPurchase of Own Shares
18th Feb 20257:00 amRNSPurchase of Own Shares
14th Feb 20257:00 amRNSPurchase of Own Shares
10th Feb 202510:00 amRNSHolding(s) in Company
5th Feb 20257:00 amRNSPurchase of Own Shares
3rd Feb 20257:00 amRNSCompleted acquisition of LIFT-Financial Group
3rd Feb 20257:00 amRNSPurchase of Own Shares
31st Jan 20257:00 amRNSPurchase of Own Shares
30th Jan 20257:00 amRNSPurchase of Own Shares
29th Jan 20257:00 amRNSPurchase of Own Shares
28th Jan 20257:00 amRNSCommencement of a share buyback programme
17th Jan 202510:45 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSQuarterly FUM & Intention to Move to Main Market
2nd Jan 202511:35 amRNSTotal Voting Rights
2nd Jan 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20242:00 pmRNSIssue of Equity to Vendors of Lucas Fettes
9th Dec 202412:00 pmRNSBlock listing Interim Review
5th Dec 20242:15 pmRNSHolding(s) in Company
3rd Dec 20249:05 amRNSTotal Voting Rights
15th Nov 20244:00 pmRNSIssue of Equity to Vendors of CST Wealth
14th Nov 20243:25 pmRNSBoard Appointment
1st Nov 20247:00 amRNSTotal Voting Rights
24th Oct 20244:24 pmRNSResult of AGM
22nd Oct 20245:15 pmRNSDirector/PDMR Dealings
16th Oct 20247:00 amRNSQuarterly Announcement of Funds under Management
8th Oct 20247:00 amRNSAcquisition of LIFT
1st Oct 20247:00 amRNSConfirmation of Director resignation and new CEO
1st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 20246:00 pmRNSDirector/PDMR Shareholding
20th Sep 20244:30 pmRNSAnnual Report and Notice of Annual General Meeting
12th Sep 20247:04 amRNSSale of Brooks Macdonald International
12th Sep 20247:02 amRNSKatherine Jones appointed Chief Financial Officer
12th Sep 20247:00 amRNSFinal results for the year ended 30 June 2024
21st Aug 20245:45 pmRNSPDMR Shareholding
12th Aug 202411:12 amRNSForm 8.3 - Tritax EuroBox plc
8th Aug 202411:46 amRNSForm 8.3 - Tritax EuroBox plc
6th Aug 202412:56 pmRNSForm 8.3 - Tritax EuroBox plc
6th Aug 20247:00 amRNSHolding(s) in Company
1st Aug 20247:00 amRNSTotal Voting Rights
31st Jul 202411:09 amRNSForm 8.3 - Tritax EuroBox plc
29th Jul 202411:51 amRNSForm 8.3 - Tritax EuroBox plc
24th Jul 202411:40 amRNSForm 8.3 - Tritax EuroBox plc
17th Jul 20247:00 amRNSQuarterly Announcement of FUM and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.